Amer Zeidan: AI in Medicine Still Needs a Reality Check

Amer Zeidan, Professor of Medicine and Chief of Hematologic Malignancies at Yale Cancer Center, shared on LinkedIn:

“This is a good example why I don’t trust AI and take everything that it says with a grain of salt. I asked about the definition of EFS in MDS using the IWG 2026 (and there are no 2026 criteria, the latest iteration was 2023), but it gave a completely misleading answer that talks about a 2026 iteration!”